Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports.

HOME
>
論文・技術情報
>
Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports.

アブストラクト
ジャーナル名	Annals of hematology
Pubmed追加日	2026/4/24
投稿者	Muratore, Edoardo; Giunchi, Valentina; Fusaroli, Michele; Baccelli, Francesco; Gottardi, Francesca; Poluzzi, Elisabetta; Masetti, Riccardo; Raschi, Emanuel
組織名	Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di;Bologna, Bologna, 40138, Italy.;Department of Medical and Surgical Sciences, University of Bologna, Bologna,;Italy.;Bologna, Bologna, 40138, Italy. francesco.baccelli3@unibo.it.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/42026320/